December 06, 2025 17:30 ET | Source: TScan Therapeutics, Inc. Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23)…
Positive results from ianalumab pivotal Phase III trial in ITP patients previously treated with corticosteroids to be presented as late-breakerScemblix…
Data spans five abstracts including two oral presentations with important findings for patients living with blastic plasmacytoid dendritic cell neoplasm (BPDCN)BPDCN…
BEIJING, Sept. 24, 2025 /PRNewswire/ -- When the "Wuliangye Day" event opened in Osaka, western Japan recently, Chinese baijiu maker…
BANGALORE, India, July 14, 2025 /PRNewswire/ -- IDeA World College, widely known as one of India's premier design schools, was…